文献速递血栓与止血

免疫性血小板减少症中自身免疫标志物的患病率与预后意义

Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance.
PubMed 文献 · Blood Adv · 2019-01-01

该回顾性研究评估了成人ITP患者自身免疫标志物的患病率,并用多因素logistic回归分析其与血栓事件或临床缓解的关联。结果显示抗核抗体(65%)、抗甲状腺过氧化物酶抗体(31%)和直接抗人球蛋白(29%)最常见;抗甲状腺过氧化物酶抗体阳性与较低缓解概率相关,狼疮抗凝物阳性与较高血栓率相关,抗核抗体与血栓强烈相关。

要点

  • ITP患者自身免疫标志物阳性率高,抗核抗体65%、抗甲状腺过氧化物酶抗体31%、直接抗人球蛋白29%。

核心结论

  • 许多ITP患者存在超出血小板自身抗体的免疫失调状态,某些自身免疫标志物可能具有预后价值。

研究设计与样本

  • 回顾性评估机构数据库成人ITP患者自身免疫标志物患病率,并用多因素logistic回归分析其与血栓事件或临床缓解的关联。

主要发现

  • 自身免疫标志物阳性率高,最常见为抗核抗体(65%)、抗甲状腺过氧化物酶抗体(31%)和直接抗人球蛋白(29%)。
  • 血小板自身抗体阳性与自身免疫标志物存在无关联。

临床怎么用

  • 当前指南不鼓励ITP患者常规检测自身免疫标志物,但某些标志物可能有助于预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prior studies have demonstrated an increased prevalence of autoimmune markers in patients with immune thrombocytopenia (ITP). Clinical experience has suggested that there may be an association between autoimmune markers and poor outcomes in ITP, but current guidelines do not encourage routine testing in these patients. We retrospectively assessed the prevalence of autoimmune markers in adult patients with ITP from our institutional database and used multiple logistic regression analyses to test for an association between autoimmune marker positivity and thrombotic events or clinical remission. We also assessed whether positivity for common autoimmune markers was associated with positivity for platelet autoantibodies. There was a high rate of autoimmune marker positivity in this population, with antinuclear antibody (65%), antithyroid peroxidase antibody (31%), and direct antiglobulin (29%) the most commonly found. Antithyroid peroxidase antibody positivity was associated with a lower probability of remission (odds ratio [OR], 0.26; 95% confidence interval [CI], 0.09-0.79; P = .017). Lupus anticoagulant positivity was associated with a higher rate of thrombosis (OR, 8.92; 95% CI, 1.94-40.95; P = .005), and antinuclear antibody was strongly associated with thrombosis (P = .001). There was no relation between platelet autoantibody positivity and the presence of autoimmune markers. These results suggest that many patients with ITP have a state of immune dysregulation that extends beyond platelet autoantibodies and that certain autoimmune markers may be prognostically useful in this disorder.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Hollenhorst MA, Al-Samkari H, Kuter DJ, et al. Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance. Blood Adv. 2019. PMID: 31730698. doi:10.1182/bloodadvances.2019000400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。